Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 8;17(3):26.
doi: 10.3390/hematolrep17030026.

Clinical Outcome and Molecular Profile in Patients with DDX41 Mutation Hot-Spots

Affiliations

Clinical Outcome and Molecular Profile in Patients with DDX41 Mutation Hot-Spots

Nadia Toumeh et al. Hematol Rep. .

Abstract

Background/Objectives:DDX41, DEAD-box RNA helicase 41 gene located on chromosome 5q25.3, is one of the most mutated genes in patients with germline predisposition to myeloid neoplasms. Germline and somatic mutations often have different locations and patterns of mutation, with some hotspots displaying diversity based on ethnicity. We aimed to explore clinical outcomes in patients with various DDX41 hot-spot mutations. Methods: This was a retrospective study of patients at Mayo Clinic with DDX41 mutation identified through Next Generation Sequencing (NGS) between 2018 and 2024. We completed unadjusted comparisons using continuous or categorical variables, and survival rates were assessed using the Kaplan-Meier method and cox regression analysis. Results: Overall survival appears to be higher in those with p.M1| when compared to p.Asp140GlyFs*2 and p.Arg525His, with comparable survival between p.Arg525His and p.Asp140GlyFs*2. Among males with p.M1| who underwent bone marrow transplant, those who underwent bone marrow transplant appeared to have lower survival rates, although not statistically significant. Our study was limited by a small sample size, therefore limiting our ability to reach significance. Conclusions: Our findings suggest potential implications for clinical outcomes based on DDX41 mutation hot-spots.

Keywords: AML; DDX41; MDS.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
(A) Distribution of DDX41 mutations, with those with isolated DDX41 mutation above the gene box and co-mutated DDX41 patients below the gene box. Black circles indicate patients without available genetic alteration information; (B) patterns of co-mutation with respective VAF among DDX41 hot-spots, with “other” demonstrating patients with mutation other than p.M1|, p.Arg525His, p.Asp140GlyFs*2; (C) Kaplan–Meier survival probability in p.M1| compared to p.Arg525His; (D) Kaplan–Meier survival probability in p.M1| compared to p.Asp140GlyFs*2; (E) Kaplan–Meier survival probability in p.Arg525His compared to p.Asp140GlyFs*2.

References

    1. Winstone L., Jung Y., Wu Y. DDX41: Exploring the roles of a versatile helicase. Biochem. Soc. Trans. 2024;52:395–405. doi: 10.1042/BST20230725. - DOI - PMC - PubMed
    1. Nagata Y. Molecular pathophysiology of germline mutations in acute myeloid leukemia. Int. J. Hematol. 2024;120:417–426. doi: 10.1007/s12185-024-03824-x. - DOI - PubMed
    1. Bataller A., Loghavi S., Gerstein Y., Bazinet A., Sasaki K., Chien K.S., Hammond D., Montalban-Bravo G., Borthakur G., Short N., et al. Characteristics and clinical outcomes of patients with myeloid malignancies and DDX41 variants. Am. J. Hematol. 2023;98:1780–1790. doi: 10.1002/ajh.27070. - DOI - PMC - PubMed
    1. Kim K., Ong F., Sasaki K. Current Understanding of DDX41 Mutations in Myeloid Neoplasms. Cancers. 2023;15:344. doi: 10.3390/cancers15020344. - DOI - PMC - PubMed
    1. Alkhateeb H.B., Nanaa A., Viswanatha D.S., Foran J.M., Badar T., Sproat L., He R., Nguyen P., Jevremovic D., Salama M.E., et al. Genetic features and clinical outcomes of patients with isolated and comutated DDX41-mutated myeloid neoplasms. Blood Adv. 2022;6:528–532. doi: 10.1182/bloodadvances.2021005738. - DOI - PMC - PubMed

LinkOut - more resources